Navigating an Optimal Treatment Course for Advanced Kidney Cancer
Benjamin A. Teply, MD, considers the optimal treatment of renal cell carcinoma in a peer perspective accompanying an article by Tiffany Y. Shaw, MD, and colleagues.
Identification and Management of Toxicities From Immune Checkpoint–Blocking Drugs
As immune checkpoint–blocking medications are administered to an increasing number of patients, clinicians must be able to recognize and treat the associated immune-related side effects.